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of the Main and Side Branches in Bifurcation
Lesions Treated With the T-Stenting Technique
Joo-Yong Hahn, MD, PHD, Young Bin Song, MD, Sang-Yup Lee, MD, Jin-Ho Choi, MD, PHD,
Seung-Hyuk Choi, MD, PHD, Duk Kyung Kim, MD, PHD, Sang Hoon Lee, MD, PHD,
Hyeon-Cheol Gwon, MD, PHD
Seoul, Republic of Korea
Objectives This study sought to investigate the mechanism of restenosis and the predictive value of post-procedural mini-
mum stent area (MSA) in the side branch (SB) after coronary bifurcation stenting.
Background The mechanism of restenosis, especially at the SB ostium, has not been fully elucidated.
Methods This study examined 73 bifurcation lesions with post-procedural and 9-month follow-up intravascular ultrasound
images for both main vessel (MV) and SB. All lesions were treated with drug-eluting stents using the T-stenting
technique. Analysis included 5 distinct locations: MV proximal stent, MV middle area, MV distal stent, SB ostium
(5 mm distal to the neocarina), and SB distal stent.
Results Stent expansion was significantly less in the SB than in the MV (87.1  20.4% vs. 97.0  29.1%, p  0.007).
The SB ostium was the most frequent site of post-procedural MSA. At the SB ostium, follow-up minimum lumen
area (MLA) correlated with post-procedural MSA (r  0.81, p  0.001). The percentage of neointimal area was
higher at the SB ostium than at the MV proximal, MV distal, and SB distal stent (23.8  18.9% vs. 13.3 
17.3%, 15.4  20.5%, and 12.5  17.2%, p  0.001). The optimal threshold of post-procedural MSA to predict
follow-up MLA 4 mm2 at the SB ostium was 4.83 mm2, yielding an area under the curve of 0.88 (95% confi-
dence interval: 0.80 to 0.95).
Conclusions Our data suggest that inadequate post-procedural MSA with increased neointimal hyperplasia may cause the SB
ostium to be the most frequent site of restenosis after percutaneous coronary intervention on bifurcation
lesions. (J Am Coll Cardiol 2009;54:110–7) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.03.042o
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bifurcation lesion percutaneous coronary intervention (PCI)
as a higher rate of restenosis than PCI for nonbifurcation
esions even in the drug-eluting stents (DES) era (1–3). In
ifurcation lesions, restenosis occurs predominantly at the
stium of the side branch (SB). However, the reason that
he SB ostium is the most frequent site of restenosis is not
ully understood. The post-procedural minimum stent area
MSA) is shown to be an independent predictor of reste-
osis after PCI with DES in nonbifurcation lesions (4).
lthough stent underexpansion is common at the SB
stium (5), there are few data on the association between
SA after PCI and restenosis in bifurcation lesions. In-
reased neointimal hyperplasia or chronic stent recoil cannot
e excluded as the causes of restenosis in bifurcation lesions.
rom the Division of Cardiology, Department of Medicine, Samsung Medical
enter, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.g
Manuscript received November 13, 2008; revised manuscript received March 4,
009, accepted March 10, 2009.The goal of this study was to investigate the mechanism
f restenosis after coronary bifurcation stenting and the
redictive value of post-procedural MSA in the SB. For this
urpose, we performed serial intravascular ultrasound
IVUS) studies in both main branches and SB immediately
fter PCI and at angiographic follow-up.
ethods
tudy population. The inclusion criteria were: 1) an elec-
ive coronary stenting with DES for a bifurcation lesion;
) main vessel (MV) reference diameter (RD)3.0 mm and
B RD 2.3 mm by visual estimation; and 3) DES in both
V and SB. Patients with hemodynamic instability or
hose undergoing primary PCI were excluded.
Between March 2005 and February 2007, 106 native
ifurcation lesions in 105 patients were treated successfully
y T-stenting and small-protrusion technique under IVUS
uidance (Fig. 1). Post-intervention IVUS for the SB was
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July 7, 2009:110–7 Serial IVUS Analysis in Bifurcation Stentingvailable in 94 lesions. Among these, angiographic
ollow-up was performed for 84 lesions in 83 patients
median 272 days, interquartile range 263 to 281 days after
rocedure) and follow-up IVUS for the SB was available in
3 lesions of 72 patients. Ten patients with available
ost-procedural IVUS data did not undergo a follow-up
oronary angiogram; 1 patient died because of angiographi-
ally documented acute stent thrombosis, 1 patient died
uddenly 38 days after the procedure, and renal failure
eveloped in 1 patient during follow-up. The other 7
atients who refused a follow-up coronary angiogram had
o adverse clinical events. At the follow-up coronary angio-
ram, the IVUS catheter could not pass because of tight
tenosis at the SB ostium in 1 lesion. The IVUS study was
ot attempted in 7 lesions: 1 because of in-stent restenosis
nvolving the MV and the SB simultaneously, 1 because of
iffuse in-stent restenosis in the MV, and 5 for no definite
ause. Among 3 lesions with lost or inadequate images for
ystemic IVUS analysis, angiographic restenosis at the SB
stium was not found. The institutional review board of
amsung Medical Center approved this study, and all
ubjects gave their informed consent to participation.
-stenting technique: T-stenting and small protrusion. Be-
ore the procedure, aspirin 300 mg and clopidogrel 300 to
00 mg were loaded if patients were not taking these drugs.
ntravenous heparin was administered to maintain an acti-
ated clotting time longer than 300 s. Administration of
lycoprotein IIb/IIIa inhibitors was at the operator’s discre-
ion. All coronary lesions were treated with T-stenting and
mall-protrusion technique (6). After stenting of the MV,
ewiring of the SB and kissing balloon inflation were
erformed if diameter stenosis was 50% at the SB ostium.
f the residual stenosis was 50% or major dissection was
bserved after kissing balloon stenting, SB stenting was
erformed. The SB stent was pulled back slightly into the
V to fully cover the ostium of SB. Before final kissing
Figure 1 Patient Flow Chart
IVUS  intravascular ultrasound; TAP  T-stenting and small-protrusion.ralloon stenting, the balloon was
ilated at as high a pressure as
ossible in both the MV and the
B sequentially to obtain an ade-
uate MSA for each vessel. Then,
nal kissing balloon stenting was
erformed at moderate pressure.
epresentative post-procedural
VUS images are shown in Figure
. Either sirolimus-eluting stents
r paclitaxel-eluting stents were
sed, but the same type of DES
as implanted in the MV and SB.
fter the procedure, aspirin (100
o 200 mg daily) was given indef-
nitely and clopidogrel (75 mg
aily) was administered for at least
year.
uantitative coronary angiog-
aphy (QCA). Baseline, post-
ntervention, and follow-up coronary angiographies were
nalyzed by 2 experienced technicians using an online QCA
ystem (Integris H3000, Philips, Hamburg, Germany). The
inimum luminal diameter (MLD) and RD before, imme-
iately after the procedure, and at follow-up were measured
n matched views. For the MV, the RD was the average of
he proximal and distal reference lumen diameters. For the
B, the RD was the distal reference lumen diameter.
iameter stenosis was calculated by: 100  (RD MLD)/
D. Angiographic restenosis was defined as a diameter
tenosis of 50% at follow-up.
VUS imaging and analysis. The IVUS examinations
ere performed on the MV and the SB in a standard
ashion (7). All IVUS images were obtained using a
ommercially available system (Boston Scientific Corpo-
ation/Cardiovascular Imaging System, San Jose, Califor-
ia) consisting of a rotating 40-MHz transducer within a
.2-F imaging sheath. Before each IVUS run, 200 g
itroglycerin was injected into the coronary artery. The
atheter was advanced approximately 10 mm beyond the
esion, and imaging was performed from there to approx-
mately 10 mm proximal to the lesion whenever possible.
he transducer was pulled back automatically at a speed
f 0.5 mm/s. Ultrasound studies were recorded on a
/2-inch high-resolution s-VHS tape and were digi-
alized later (before November 2005) or recorded digitally
after November 2005) for offline analysis.
Quantitative IVUS analysis was performed using com-
uterized planimetry (echoPlaque, Indec System, Mountain
iew, California) by 2 experienced observers following the
riteria of the American College of Cardiology Clinical
xpert Consensus Document on IVUS (8). The cross-
ectional areas of the lumen, stent, and the external elastic
embrane were measured. In the MV, the proximal and
istal references were analyzed, whereas only the distal
Abbreviations
and Acronyms
DES  drug-eluting stent(s)
IVUS  intravascular
ultrasound
MLA  minimum luminal
area
MLD  minimum luminal
diameter
MSA  minimum stent
area
MV  main vessel
PCI  percutaneous
coronary intervention
QCA  quantitative
coronary angiography
RD  reference diameter
SB  side brancheference was analyzed in the SB. The reference sites were
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Serial IVUS Analysis in Bifurcation Stenting July 7, 2009:110–7hosen as the image slices with the least amount of plaque
ithin 10 mm proximal and distal to the lesions. Stent
xpansion was defined as MSA divided by distal reference
umen area. Percentage of neointimal area was calculated as:
00  (stent area  lumen area)/stent area. Based on
revious studies, adequate minimum luminal area (MLA) at
ollow-up was defined as 4 mm2 (9). Bifurcation lesions
ere divided into 5 segments for analysis based on the
reviously used method with modification (Fig. 3) (5):
MV proximal stent: between the proximal stent edge of
the MV and the most proximal part of the neocarina area
MV middle area: between the most proximal part of the
neocarina and 5 mm distal to the neocarina in the MV
stent
MV distal stent: 5 mm distal to the neocarina in the
MV stent
SB ostium: 5 mm distal to the neocarina in the SB stent
SB distal stent: 5 mm distal to the neocarina in the SB
stent
tatistical analysis. Data are expressed as mean  SD or
requencies. Continuous variables were analyzed using the
aired t test and categorical variables using a Pearson
hi-square or Fisher exact test. Statistical comparisons
mong 3 or more parameters were performed by the
Figure 2 Representative Images of Post-Procedural Intravascul
The neocarina was observed, and the side branch (SB) stent was slightly pulled ba
fully covered, and stents were well apposed against the vessel wall. D1  first diariedman test and post hoc analysis with the least signifi-ant difference test using ranks for multiple comparisons.
he p values are 2-tailed, and p  0.05 was considered
ignificant. All analyses were performed with the Statistical
nalysis Software package (SAS version 9.1, SAS Institute,
ary, North Carolina).
trasound
o the main vessel. The SB ostium was
branch; LAD  left anterior descending artery.
Figure 3 Schematic Diagram of
Intravascular Ultrasound Analysis
Schematic diagram of intravascular ultrasound analysis and location of post-
procedural minimum stent area in the main vessel (MV) and the side branch (SB).ar Ul
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July 7, 2009:110–7 Serial IVUS Analysis in Bifurcation Stentingesults
atient characteristics. Baseline characteristics are pre-
ented in Table 1. The left anterior descending artery
esions were most common. Two-thirds of the lesions were
rue bifurcations. Sirolimus-eluting stents were used pre-
ominantly, and final kissing balloon stenting was per-
ormed in all lesions.
ngiographic and procedural data. Angiographic and
rocedural data are shown in Table 2. The RD was smaller
nd lesions were significantly shorter in the SB than in the
V. The post-procedural stent MLD was significantly
maller in the SB than in the MV. At follow-up, stent
LD was significantly smaller in the SB than in the MV,
ut the percent diameter stenosis was similar. Late loss was
ot significantly different between the MV and SB. Angio-
raphic restenosis was noted in 6 lesions (8.2%) in the MV
nd in 9 lesions (12.3%) in the SB: 6 lesions were focal
estenosis at the SB ostium, 2 lesions were diffuse restenosis
nvolving the SB ostium, and 1 lesion occurred in the SB
istal stent. The total restenosis rate per bifurcation lesion
restenosis of either the MV, the SB, or both) was 17.8%
13 of 73 lesions). Target lesion revascularization was
erformed in 5 lesions (6.8%).
VUS data. The IVUS showed that the distal reference
ross-sectional area and post-procedural MSA were smaller
n the SB than the MV (Table 3). Stent expansion was
aseline Characteristics*
Table 1 Baseline Characteristics*
Age (yrs) 62 9
Male 52 (71)
Hypertension 41 (56)
Diabetes 16 (22)
Dyslipidemia 11 (15)
Current smoking 13 (18)
Prior myocardial infarction 4 (6)
Acute coronary syndrome 28 (38)
Site of bifurcation
Distal left main stem 31 (42)
Left anterior descending/diagonal 34 (47)
Left circumflex/obtuse marginal 6 (8)
Right coronary/posterior descending 2 (3)
Type of bifurcation according to Medina classification
1,1,1 36 (49)
1,1,0 10 (14)
1,0,1 3 (4)
1,0,0 5 (7)
0,1,1 10 (14)
0,1,0 6 (8)
0,0,1 3 (4)
True bifurcation† 49 (67)
Angle between main and side branch (°) 58 22
Stents used
Sirolimus-eluting stent 57 (78)
Paclitaxel-eluting stent 16 (22)
Final kissing balloon 73 (100)alues are expressed as n (%) or mean SD. *n 73 lesions in 72 patients. †Medina classification
1,1,1), (1,0,1), or (0,1,1). mignificantly less in the SB than in the MV. Incomplete
pposition was found in the MV middle area in 3 cases (2
ases at the neocarina and 1 case distal to the neocarina) and
n the SB ostium in 3 cases after the procedure. The length
f protruding stents was 2.7  1.4 mm. In 6 cases (8.2%),
he SB ostium was not fully covered. Of these, the angle
etween the main branch and SB was 60° in 5 cases.
owever, the uncovered length was very short (1 to 2 struts)
n 5 cases and 3 mm even in the worst case. In the MV,
he post-procedural MSA differed significantly according to
ocation (p  0.001). The MSA was largest in the MV
roximal stent and smallest in the MV distal stent. Con-
idering the whole MV, the MV distal stent was the most
ngiographic and Procedural Data
Table 2 Angiographic and Procedural Data
Main Vessel Side Branch p Value
Angiographic data
Pre-procedural
Reference diameter (mm) 3.03 0.75 2.49 0.67 0.001
MLD (mm) 1.01 0.81 1.17 0.60 0.10
Diameter stenosis (%) 66.7 25.3 51.0 29.5 0.001
Lesion length (mm) 14.25 7.95 5.77 5.01 0.001
Post-procedural
Stent MLD (mm) 2.85 0.60 2.46 0.57 0.001
At follow-up
Reference diameter (mm) 3.20 0.71 2.56 0.59 0.001
Stent MLD (mm) 2.39 0.71 1.91 0.63 0.001
Stent diameter stenosis (%) 24.8 20.5 24.7 20.4 0.96
Late loss 0.45 0.72 0.53 0.75 0.35
Procedural data
Stent diameter (mm) 3.33 0.29 3.01 0.39 0.001
Stent length (mm) 27.04 5.61 20.41 6.71 0.001
Maximum pressure (atm) 15.4 2.9 15.3 2.7 0.81
alues are expressed as mean SD.
MLD  minimum luminal diameter.
ntravascular Ultrasound Data
Table 3 Intravascular Ultrasound Data
Main Vessel Side Branch p Value
Post-procedural
Proximal reference lumen CSA (mm2) 13.1 5.2 — —
Distal reference lumen CSA (mm2) 6.5 2.3 5.5 2.4 0.002
MSA (mm2) 6.1 1.9 4.7 1.8 0.001
MV proximal 10.0 3.3 — —
MV middle/SB ostium 6.8 1.8 5.0 1.8 0.001
Distal 6.3 2.1 5.0 2.1 0.001
Stent expansion* (%) 97.0 29.1 87.1 20.4 0.007
At follow-up (mm2)
Proximal reference lumen CSA 12.2 4.9 — —
Distal reference lumen CSA 6.9 2.5 5.9 2.3 0.002
MLA (mm2) 5.3 1.8 4.1 1.7 0.001
MV proximal 9.0 3.3 — —
MV middle/SB ostium 6.0 1.9 4.4 1.8 0.001
Distal 5.7 2.3 4.7 2.2 0.001
Stent area at the MLA site 6.7 2.0 5.1 1.9 0.001
alues are expressed as mean  SD. *Defined as MSA divided by distal reference lumen area.
CSA  cross-sectional area; MLA  minimum lumen area; MSA  minimum stent area; MV 
ain vessel; SB  side branch.
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Serial IVUS Analysis in Bifurcation Stenting July 7, 2009:110–7requent site of post-procedural MSA (Fig. 3). Post-
rocedural MSA was similar between the ostium and distal
tent in the SB. However, considering the whole SB, the
ost-procedural MSA was found more frequently at the SB
stium than the SB distal stent (Fig. 3). When both the MV
nd the SB were considered, MSA was found in the SB in
9% of cases, and the SB ostium was the most frequent site
f post-procedural MSA (42%) despite a length of only
round 5 mm.
At follow-up, MLA was significantly smaller in the SB
han in the MV (Table 3). In the MV, MLA differed
ignificantly according to the location (p  0.001). In the
B, MLA at the ostium had a tendency to be smaller than
istal MLA (p 0.06). Although MLA of the MV was4
m2 in 56 lesions (77%), MLA of the SB was 4 mm2 in
nly 26 lesions (36%). Chronic stent recoil was not ob-
erved: stent area at the MLA site was not significantly
ifferent from post-procedural MSA. When we focused on
he SB ostium and the MV middle area, there was a
ignificant correlation between post-procedural MSA and
LA at follow-up in the corresponding segments (Fig. 4).
he percentage of neointimal area was significantly higher
n the SB ostium compared with the MV proximal, MV
istal, and SB distal stent (23.8  18.9% vs. 13.3  17.3%,
5.4  20.5%, and 12.5  17.2%, respectively, p  0.001)
Fig. 5). The MV middle area showed a significantly higher
ercentage of neointimal area (19.7  15.8%) than the MV
roximal, MV distal, and SB distal stent as well. There was
o significant difference in the percentage of neointimal area
mong the MV proximal, MV distal, and SB distal stent.
The receiver-operator characteristic curve identified that
he optimal cutoff value of post-procedural MSA at the SB
stium to predict adequate follow-up MLA in the SB was
.83 mm2, yielding an area under the curve of 0.88 (95%
onfidence interval: 0.80 to 0.95) (Fig. 6). The positive
Figure 4 Correlation Between Post-Procedural MSA and Follow
Correlation between post-procedural minimum stent area (MSA) and follow-up miniredictive value with this cutoff point was 70%. However,
here was no significant difference in the rate of focal
estenosis at the SB ostium between bifurcation lesions with
ost-procedural MSA at the SB ostium 4.83 mm2 (n 
3) and those with post-procedural MSA at the SB ostium
4.83 mm2 (n  40) (9.1% vs. 7.5%, p  0.81). The target
esion revascularization rate was also similar in both groups
6.1% vs. 7.5%, p  0.99).
The optimal cutoff value of post-procedural MSA at the
V middle area to predict adequate follow-up MLA in the
V was 6.14 mm2, yielding an area under the curve of 0.81
95% confidence interval: 0.64 to 0.99). The positive pre-
ictive value with this cutoff point was 91%.
LA
uminal area (MLA) at the side branch ostium and the main vessel middle area.
Figure 5 Percentage of Neointimal Hyperplasia
Percentage of neointimal hyperplasia (100  neointimal area/stent area)
according to each segment. *p  0.001 versus the SD ostium; †p  0.01 ver-
sus the MV middle area; ‡p  0.05 versus the MV middle area. Abbreviations
as in Figure 3.-Up M
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July 7, 2009:110–7 Serial IVUS Analysis in Bifurcation Stentingiscussion
n the present study, we performed a serial IVUS study in both
he main branches and SB of bifurcation lesions treated with 2
ES by T-stenting and the small-protrusion technique. The
ost-procedural MSA was smaller and stent expansion was
ignificantly less in the SB than in the MV. The MLA at
ollow-up correlated significantly with the post-procedural
SA in both branches. The percentage of neointimal area is
ignificantly higher in the SB ostium and MV middle area
ompared with other segments. To our knowledge, this is the
rst study to perform serial IVUS analysis on both branches
mmediately after procedure and at follow-up.
Restenosis rates after PCI on bifurcation lesions are still
igh, even with DES (1–3). However, the mechanism of
estenosis and the reasons the SB ostium is the most frequent
ite of restenosis are not fully understood. A serial IVUS study
howed that DES is very effective at reducing neointimal
yperplasia and, in turn, increased predictability of post-
rocedural MSA for stent long-term patency (10). Moreover,
ost-procedural MSA is an independent predictor of angio-
raphic restenosis (4). Bifurcation lesions, however, were ex-
luded in these studies. Therefore, the predictive value of
ost-procedural MSA in the SB and the optimum threshold to
redict adequate follow-up MLA in the SB have not been
nown. The role of increased neointimal hyperplasia or chronic
tent recoil for restenosis in bifurcation lesions has not been
etermined. To elucidate the mechanism of restenosis in
ifurcation lesions, serial IVUS studies of both the MV and the
B are mandatory, as shown in the present study.
echanism of restenosis. Previous studies reported that
ost cases of restenosis occurred at the SB ostium (1,3). Costa
t al. (5) performed an IVUS study on bifurcation lesions
reated with the crush technique and showed that the majority
Figure 6 The Optimal Cutoff Value of Post-Procedural MSA
The receiver-operator characteristic curve showing the optimal cutoff value of post
SB ostium (A) and at the MV middle area (B) to predict adequate follow-up mif SB lesions had stent underexpansion and the smallest MSA sas typically found at the SB ostium. Consistent with the
revious study, post-procedural MSA was smaller and stent
xpansion was significantly less in the SB than in the MV in
ur study. The smallest MSA was found most frequently at the
B ostium. Moreover, MLA at follow-up significantly corre-
ated with post-procedural MSA not only in the MV but also
n the SB. Collectively, stent underexpansion or inadequate
ost-procedural MSA seems to contribute considerably to
estenosis at the SB ostium.
Increased neointimal hyperplasia might explain the higher
ate of restenosis in bifurcation lesions compared with nonbi-
urcation lesions. Angiographic late loss seemed to be greater
n the SB than in the MV in previous studies on bifurcation
esions treated with DES (1). In the present study, we showed
hat neointimal hyperplasia was increased significantly at the
B ostium and MV middle area compared with other seg-
ents. Bifurcation sites are predisposed to early development
f atherogenesis, and this may be related to variable shear
orces produced by bifurcation (11). Bifurcation lesions showed
arked intimal hyperplasia (12). Even after stenting, there is a
ossibility that neointimal hyperplasia increases in bifurcation
esions because of low shear stress. Although the MV middle
rea showed significantly increased neointimal hyperplasia
ompared with other segments as the SB ostium did, the
ifference in post-procedural MSA between the MV middle
rea and the SB ostium may explain why restenosis selectively
nvolved the SB ostium.
Because stenting reduces initial elastic recoil and limits
egative arterial remodeling (13), chronic stent recoil can be a
ery rare cause of in-stent restenosis in nonbifurcation lesions.
owever, bifurcation lesions have a special geometry and may
ave external constrictive forces. The MV stents may chroni-
ally compress SB stents. Nonetheless, in our serial IVUS
ural minimum stent area (MSA) at the
luminal area. Abbreviations as in Figure 3.-proced
nimumtudies, stent area of the MLA site at follow-up was not
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Serial IVUS Analysis in Bifurcation Stenting July 7, 2009:110–7ecreased compared with post-procedural MSA. Our data
uggested that chronic stent recoil contributes minimally, if at
ll, to restenosis in bifurcation lesions.
redictive value of post-procedural MSA. In this study,
he optimal cutoff value of post-procedural MSA in the SB to
redict adequate follow-up MLA in the SB ostium was 4.83
m2. In the IVUS substudy of the SIRIUS (Sirolimus-
luting Stent Versus Standard Stents in Patients With Steno-
is in Native Coronary Artery) trial, the optimal threshold of
ost-procedural MSA to predict adequate follow-up MLA
as 4.5 mm2 in the small coronary arteries (2.8 mm as
easured by QCA) of nonbifurcation lesions (10). Consider-
ng that the vessel size of the SB was about 2.5 mm in our
tudy, the optimal cutoff value of post-procedural MSA to
redict adequate follow-up MLA in the SB ostium seemed to
e larger than that in nonbifurcation lesions. In addition, the
ositive predictive values with the cutoff point of 4.83 mm2
ere 70%, somewhat lower compared with the IVUS substudy
f the SIRIUS trial. Increased neointimal hyperplasia in the SB
ay lower the predictability of post-procedural MSA.
tudy strengths and limitations. Our study had some
trengths. First of all, we performed serial IVUS studies of both
he MV and the SB. All lesions were treated with the same
echnique: T-stenting and small-protrusion technique, which
xcluded confounding derived from a difference in stenting
echniques. Furthermore, final kissing ballooning was per-
ormed in all lesions. Most follow-up coronary angiograms
ere uniformly performed at 9 months.
Differences between the previous study by Costa et al.
5) and ours should be pointed out. Above all, we
erformed a follow-up IVUS study, which had not been
one in the previous study. As mentioned in the paper by
osta et al. (5), serial IVUS study of both branches at
mplantation and follow-up would be required to eluci-
ate the mechanism of restenosis after PCI on bifurca-
ion lesions. Moreover, our study included nearly 3 times
s many patients as did the study by Costa et al. (5).
ost-procedural IVUS findings showed some discordance
etween the 2 studies: the MSA of the SB was larger in
ur study compared with the Costa et al. (5) study,
hereas it was the opposite regarding the MV; when only
he MV was considered, the MSA was found in the crush
rea rather than the distal stent in the Costa et al. (5)
tudy, but the MV distal stent was the most frequent site
f post-procedural MSA in our study. The following
ifferences may explain this discordance. First, the treat-
ent strategy was different: crush technique versus pro-
isional T-stenting. Second, although we divided bifur-
ation lesions into 5 segments for analysis based on the
ethod used by Costa et al. (5), the definition of some
egments in our study differed from that in the previous
tudy.
There are several limitations to our study. First, our study
id not have the power to make any conclusion on angio-
raphic restenosis and revascularization because of the small
umber of events. Second, our results cannot be generalizedo all bifurcation lesions because we studied only bifurcation
esions treated with 2 DES using T-stenting and small-
rotrusion technique. Third, follow-up coronary angio-
rams and IVUS studies were not performed on all lesions
ith available post-procedural MSA. Nevertheless, the
ollow-up angiogram rate was about 90% and the follow-up
VUS rate was about 80%, which was fairly high. Fourth,
lthough we used T-stenting and small-protrusion tech-
ique for ensuring stent coverage at the SB ostium, the SB
stium was not fully covered in 6 cases. Incomplete stent
overage may contribute to restenosis at the SB ostium. It is
mportant to fully cover the SB ostium with the stent to
inimize this issue.
onclusions
e performed serial IVUS studies in both the MV and the
B immediately after PCI and at 9-month follow-up to
nvestigate the mechanism of restenosis after PCI on bifur-
ation lesions and the predictive value of post-procedural
SA at the SB ostium. In bifurcation lesions treated with
DES, follow-up MLA correlated significantly with post-
rocedural MSA, and neointimal hyperplasia was found to
e increased at the SB ostium. Our data suggest that both
nadequate post-procedural MSA and increased neointimal
yperplasia are the major mechanisms of an increased
estenosis rate in the SB ostium.
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